Company / Tangible Book Value per Share
Aclaris Therapeutics, Inc. Tangible Book Value per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$0.96
FY2025
5-year range
$0.96 / $4.37
FY2021-FY2025
Trend
-56.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Tangible Book Value per Share has declined for 7 consecutive years, from $6.37 in FY2018 to $0.96 in FY2025.
Based on SEC 10-K filings.
0.96 in FY2025 with a 5-year CAGR of -28.7%.
Declined from $2.96 to $0.96 over the past 2 years.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -33.3%
- 5-Year CAGR
- -28.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- Aclaris Therapeutics, Inc.'s tangible book value per share has declined for 7 consecutive years.
- In FY2025, tangible book value per share decreased 56.9% year-over-year.
- Peak tangible book value per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.96 | -56.9% |
| FY2024 | $2.22 | -25.2% |
| FY2023 | $2.96 | -8.2% |
| FY2022 | $3.23 | -26.2% |
| FY2021 | $4.37 | -15.6% |
| FY2020 | $5.19 | -5.1% |
| FY2019 | $5.47 | -14.2% |
| FY2018 | $6.37 | +124.3% |
| FY2017 | $2.84 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026